Connect with us

Hi, what are you looking for?

Editor's Pick

201 House Democrats vote against blocking Medicaid dollars for kids’ transgender surgeries

More than 200 House Democrats voted against banning Medicaid dollars from funding transgender treatments for minors.

The Do No Harm in Medicaid Act was introduced by Rep. Dan Crenshaw, R-Texas, and received support from all House Republicans when it was put to a vote Thursday afternoon.

The measure passed 215-201, with all opposition coming from Democrats. All Republicans who voted approved the bill.

Four Democratic representatives voted for the bill — Henry Cuellar, D-Texas; Vicente Gonzalez, D-Texas; Don Davis, D-N.C.; and Marie Gluesenkamp Perez, D-Wash.

Transgender issues, particularly related to minors, have been one of the topics driving a wedge between moderate and progressive Democrats.

The bill would block federal reimbursement for specific gender surgeries performed on minors and treatments such as hormone therapies, according to the legislative text.

The legislation could also block Medicaid funding to states that do allow federal funds to be used for transgender medical treatments for minors.

But the bill provides exceptions for puberty blockers prescribed during precocious puberty and gender-related surgeries performed to fight injury, illness and the potential death of a child, among others.

House Energy & Commerce Committee Chairman Brett Guthrie, R-Ky., said the legislation would save $445 million over a decade for the Medicaid program during debate on the bill Thursday.

Guthrie said it did not prevent children from getting medically necessary treatment, adding it ‘simply prohibits the use of Medicaid funding on specified procedures that are medically unnecessary.’

‘I’m not sure my colleagues even believe what they’re saying,’ Crenshaw said during his turn to speak. ‘Today’s great sin in medicine is perhaps one of the worst that we’ve seen in human history — a sick, twisted ideology parroted by social media, fueling social confusion.’

But Rep. Frank Pallone, D-N.J., called it an ‘extreme attack on medically necessary treatment for children.’

‘This is Congress seeking to ban healthcare for the most vulnerable among us,’ Rep. Mark Takano, D-Calif., said. ‘The healthcare that trans youth receive is a decision that they should be able to make in consultation with their parents, therapists and doctors, not politicians.

‘The hypocrisy of this legislation is staggering,’ he added, arguing the medical procedures it bans ‘allows for the same exact care for non-transgender youth.’

This post appeared first on FOX NEWS

    Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!


    By signing up, you're cool with getting emails from us. Don’t worry—your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    You May Also Like

    Investing

    Fisker (NYSE: FSR) stock price has been one of the best-performing electric vehicle (EV) stocks this week even as Tesla slumped. The shares jumped...

    Investing

    Newmont (NYSE: NEM) reported mixed financial results even as the price of gold approached its all-time high. In all, the company’s earnings per share...

    Investing

    The Fox Corporation (NASDAQ: FOX) stock price has been under pressure as investors come to terms with the abrupt firing of Tucker Carlson. The...

    Investing

    NatWest (LON: NWG) share price rose sharply, helped by the strong results from Barclays. The stock jumped to a high of 274.8p, which was...




    Disclaimer: Oldamericanbroker.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the-company.


    Copyright © 2025 Oldamericanbroker.com